,,iv #aaith ,,congress #ast ,session ,h4 ,,res4 #dhd ,,in ,,the ,,house ,,of ,,representatives ,june #f1 #bjbe,mrs4 ,dingell submitted the following resolution2 which was referred to the ,committee on ,energy and ,commerce ,,resolution ,expressing support for the recognition of ,hidradenitis ,suppurativa ,awareness ,week4 ,whereas ,hidradenitis ,suppurativa 7in this resolution referred to as ,,hs7 is a chronic1 inflammatory skin disease that affects approximately #c1cjj1jjj people in the ,united ,states2 ,whereas ,,hs causes painful1 boil-like nodules and abscesses anywhere on the body1 and can progress to form tunnels under the skin and cause extensive scarring2 ,whereas individuals with ,,hs frequently suffer from #e primary domains of physical and emotional suffering1 pain1 drainage1 odor1 itching1 and profound psychological distress2 ,whereas ,,hs is associated with one of the highest completed suicide rates among dermatological diseases1 second only to melanoma2 ,whereas #ge percent of individuals with ,,hs are misdiagnosed or not diagnosed until after age #be1 missing critical windows for early intervention and care2 ,whereas delayed diagnosis contributes to worsening disease progression1 higher healthcare costs1 avoidable emergency room visits1 and unnecessary procedures2 ,whereas individuals are often diagnosed with ,,hs in the prime of their lives1 affecting their ability to work1 maintain relationships1 and participate fully in society2 ,whereas1 as of ,june #a1 #bjbe1 there are only #c biologic therapies approved by the ,food and ,drug ,administration for the treatment of ,,hs2 ,whereas additional research is urgently needed to develop new treatments1 understand the pathogenesis of the disease1 identify biomarkers of ,,hs1 and improve outcomes for ,,hs patients2 ,whereas ,federal policy can play a critical role in improving access to biologic therapies1 wound care1 and comprehensive care for ,,hs patients2 and ,whereas designating the first week of ,june as ,hidradenitis ,suppurativa ,awareness ,week would increase public awareness1 foster understanding1 and catalyze progress in diagnosing1 treating1 and ultimately curing ,,hs3 ,now1 therefore1 be it ,that the ,house of ,representatives-- 7#a7 supports the recognition of ,hidradenitis ,suppurativa ,awareness ,week2 and 7#b7 recognizes the importance of-- 7,a7 increasing awareness and education about ,,hs among the public and health professionals2 7,b7 promoting timely and accurate diagnosis of ,,hs through improved screening and culturally competent care2 7,c7 supporting biomedical research to better understand ,,hs pathogenesis1 treatment efficacy1 and long-term outcomes2 7,d7 accelerating the development of effective treatments and expanding access to existing therapies for ,,hs2 and 7,e7 advancing policies that address disparities in access to care for patients with ,,hs and improve the quality of life for individuals living with ,,hs and the caregivers of such individuals4